Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
6 pending office actions • 4 art units • 5 examiners • 0 of 6 (0%) have an AI response strategy ready
Kindeva Drug Delivery L.P. manages 6 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed among 5 distinct examiners and 4 distinct art units. The use of 4 distinct art units suggests that the company's drug delivery innovations are being reviewed by several different specialized groups at the patent office.
HAGHIGHATIAN, MINA is the busiest examiner for the portfolio, currently handling 2 pending office actions. While HAGHIGHATIAN, MINA has the highest individual count, these 2 actions represent a portion of the 6 total pending office actions for the company. The remaining pending actions are split among other distinct examiners, indicating that most examiners are managing only a single case for the company. This spread of work across multiple examiners and units reduces the impact of any single examiner's tendencies on the overall portfolio.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (33%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 3 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAGHIGHATIAN, MINA | 2 | 46.1% | +39.3% |
| CHANG, THOMAS ZHU | 1 | 50.0% | +65.8% |
| CHI, AMANDA LYNN | 1 | — | — |
| MOK, ANDREW JUN-WAI | 1 | 53.3% | +65.4% |
| GHALI, ISIS A D | 1 | 27.9% | +41.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17921774 | ADHESIVE ARTICLE AND METHOD OF MAKING SAME | MOK, ANDREW JUN-WAI | 49d overdue |
| 18606272 | FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION | HAGHIGHATIAN, MINA | 5d overdue |
| 17612132 | Removable Film-Forming Gel Compositions Featuring Adhesion Promoters | GHALI, ISIS A D | 50d |
| 18694108 | INHALER AUTHORISATION APPARATUS AND AN INHALER INCLUDING SUCH AN APPARATUS | CHANG, THOMAS ZHU | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17921774 | ADHESIVE ARTICLE AND METHOD OF MAKING SAME | MOK, ANDREW JUN-WAI | 49d overdue |
| 18606272 | FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION | HAGHIGHATIAN, MINA | 5d overdue |
| 17612132 | Removable Film-Forming Gel Compositions Featuring Adhesion Promoters | GHALI, ISIS A D | 50d |
| 18694108 | INHALER AUTHORISATION APPARATUS AND AN INHALER INCLUDING SUCH AN APPARATUS | CHANG, THOMAS ZHU | — |
| 17620325 | AEROSOL FORMULATION, CANISTER, AND INHALER CONTAINING THE FORMULATION, AND METHOD OF USE | HAGHIGHATIAN, MINA | — |
| Art Unit | Apps |
|---|---|
| 1616 | 2 |
| 1627 | 1 |
| 3786 | 1 |
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18694108 | INHALER AUTHORISATION APPARATUS AND AN INHALER INCLUDING SUCH AN APPARATUS | CHANG, THOMAS ZHU | — | §102§103§112 | Non-Final OA | — | Pending | Mar 21, 2024 |
| 18606272 | FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION | HAGHIGHATIAN, MINA | 1616 | §103§112 | Non-Final OA | 5d overdue | Pending | Mar 15, 2024 |
| 18689579 | PROPELLANTS FOR ANTICHOLINERGIC AGENTS IN PRESSURIZED METERED DOSE INHALERS | CHI, AMANDA LYNN | 1627 | §103 | Non-Final OA | — | Pending | Mar 06, 2024 |
| 17921774 | ADHESIVE ARTICLE AND METHOD OF MAKING SAME | MOK, ANDREW JUN-WAI | 3786 | §102§103§112 | Non-Final OA | 49d overdue | Pending | Oct 27, 2022 |
| 17620325 | AEROSOL FORMULATION, CANISTER, AND INHALER CONTAINING THE FORMULATION, AND METHOD OF USE | HAGHIGHATIAN, MINA | 1616 | §103§112DP | Non-Final OA | — | Pending | Dec 17, 2021 |
| 17612132 | Removable Film-Forming Gel Compositions Featuring Adhesion Promoters | GHALI, ISIS A D | 1611 | §103Other | Non-Final OA | 50d | Pending | Nov 17, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial